1031863

CSL Behring LLC — FEI 3000215763

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 9, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
King Of Prussia, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)